Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiefenbacher Group
Hamburg, Germanytiefenbachergroup.com ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Commercial
01
Overview
Tiefenbacher Group has a long track record of developing, manufacturing, and registering finished dosage forms—including highly potent drugs—and distributing APIs globally. They have achieved first approvals for new chemical entities and maintain a large portfolio of generic and innovative medicines distributed in over eighty countries. No detailed clinical trial results are published.
- Therapeutic areas
- OtherNeurology
- Modalities
- Small moleculeDrug-device combinationMedical device
- Industry
- Biotech
02
Partnerships
Not specifically listed; the company licenses out its dossiers/products to marketing partners worldwide and collaborates with API producers and global pharma brands.
Beyond the preview
Go deeper on Tiefenbacher Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tiefenbacher Group.